// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Reworking the post-COVID waiting list – the patient experience of implantable loop recorder explantation

Rahul Chattopadhyay - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Evaluating long term performance of micra VA leadless pacemaker

Omar Shaikh - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Implantable cardioverter-defibrillators in the elderly: a single-centre observational study on outcomes in octogenarians

Shermayne Ng - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A mixed-reality holographic viewing platform enabling interaction with 3D electroanatomical maps using the hololens

Anura Malaweera - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Systemic review of allergies and treatment to components of cardiac implantable electronic devices

Tharindra Dissanayake - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact of COVID-19 pandemic on in-patient mortality of patients with implantable cardiac devices

Ronald Manorekang - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Systematic review of safety and efficacy of renal sympathetic denervation for the management of cardiac arrhythmias

Nakulan Nantha Kumar - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A tertiary centre experience comparing new temperature-controlled high-power short-duration ablation technology with standard radiofrequency and cryo-energy ablation

Akash Mavilakandy - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Amiodarone follow-up in ’tracker clinic’

Tm Tanzil-Al-Imran - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Structural Heart Disease

Amiodarone Hydrochloride

In-depth proteomic characterisation of different aetiologies of cardiomyopathy

Claire Tonry - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Clinical, physical, cognitive and social frailty in patients with chronic heart failure: prevalence and associations with outcome

shirley sze - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Gender disparity in heart failure research

Holly Morgan - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Life-course environment-wide association study (EWAS) for left ventricular diastolic dysfunction in the 1946 British birth cohort

Eamon Dhall - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular diastolic dysfunction

N/A

Clinician experiences of 1 year of telemedicine heart failure clinics: the video-HF study

Arvind Singhal - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Hospital admissions in the last year of life in patients with heart failure

Alexandra Abel - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart failure with reduced ejection fraction

N/A

Effect of UK COVID-19 public health measures on activity and quality of life in patients with pulmonary arterial hypertension

Jennifer Middleton - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Coronary imaging of cardiac allograft vasculopathy predicts current and future deterioration of left ventricular dysfunction in patients with orthotopic heart transplantation

Ashwin Reddy - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac allograft vasculopathy

N/A

Comparing the safety and feasibility of implanting pulmonary artery pressure monitors via the internal jugular vein compared to standard femoral venous access in patients with pulmonary arterial hypertension

Jennifer Middleton - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

Cardiac metabolic flexibility and myocardial substrate utilisation in response to pharmacological stress in type 2 diabetes

Lavanya Athithan - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Dobutamine

Is heart failure admission over weekends and bank holidays associated with higher risk of death?

Reham Awad - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Copyright © 2026. QuantiNova All rights reserved